Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Akoya Biosciences (AKYA) News Today

Akoya Biosciences logo

AKYA Latest News

AKYA Akoya Biosciences, Inc. - Seeking Alpha
Akoya expands portfolio with new ADC breast cancer assay at AACR 2025
Piper Sandler Remains a Hold on Akoya Biosciences (AKYA)
Quanterix: Still Many, Many Questions
Akoya Biosciences downgraded to Equal Weight from Overweight at Stephens
Tikvah intends to vote against Quanterix’s proposed merger with Akoya
Akoya Biosciences (AKYA) Receives a Hold from Craig-Hallum
Akoya Biosciences reports Q4 EPS (17c), consensus (16c)
Akoya Biosciences unveils strategic product roadmap
Quanterix price target lowered to $11 from $15 at TD Cowen
Akoya Biosciences Inc AKYA
Akoya climbs after merger deal with Quanterix
Quanterix To Buy Akoya Biosciences In All Stock Deal; QTRX Up In Pre-Market
Akoya Biosciences, NeraCare enter exclusive global license agreement
Get Akoya Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AKYA Media Mentions By Week

AKYA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AKYA
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

AKYA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AKYA Articles
This Week

0

0

AKYA Articles
Average Week

Get the Latest News and Ratings for AKYA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:AKYA) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners